Healthcare marketers have spent the better part of a decade building omnichannel marketing strategies. The investments have been real: new platforms, expanded channel mixes, larger digital teams, and enough vendor relationships to fill a conference room. And yet, for many organizations, the experience they deliver to healthcare professionals and patients still feels fragmented. An HCP gets a rep visit on Monday, a generic email on Wednesday, and a programmatic ad on Thursday that has no idea the other two happened. That’s not omnichannel. That is multichannel wearing a better name tag.

As an agency, we are frequently asked to ideate novel channels or tactics that will move the needle for brands as part of their “omnichannel” mix. But the conversation has not changed much in five years. The gap between omnichannel as a concept and omnichannel as a lived experience is not primarily a channel problem. It is a data problem. And until organizations treat it that way, the investments will keep outpacing the outcomes.

Redefining What “Omnichannel” Actually Means

Most of us in healthcare marketing have moved past the surface-level distinction between multichannel (being present in many places) and omnichannel, where those places talk to each other and the engagement adapts based on what you know about the customer across all of them.

But even that definition undersells the complexity. True omnichannel maturity exists on a spectrum, and most organizations are not as far along as they think. A useful way to think about it is a five-stage maturity model:

Stage 1: Channel-Centric. Teams operate in silos. Each channel has its own plan, its own data, and its own definition of success. There is coordination in name only.

Stage 2: Coordinated. There is some intentional alignment across channels, usually driven by campaign calendars and shared messaging. But the underlying data still does not flow across functions.

Stage 3: Data-Informed. Insights are shared more broadly. Teams reference common metrics and customer data. But integration is limited and often manual. The system is reactive rather than responsive.

Stage 4: Orchestrated. Engagement is personalized in near-real time based on unified customer data. Channel selection and sequencing are driven by what the customer has done, not just what the plan says should happen next.

Stage 5: Adaptive/Intelligent. AI and predictive analytics drive next-best-action decisions. The system learns and adjusts continuously. Engagement is proactive, personalized, contextually relevant, and tied directly to measurable outcomes.

Most pharma organizations today sit somewhere between Stage 2 and Stage 3. The jump to Stage 4 is a big one, and it is almost entirely a data integration challenge. Part 2 of this series takes that challenge on directly. https://deerfieldgroup.com/news/the-omnichannel-promise-pt2

There is, however, another constraint worth naming that most omnichannel discussions gloss over: the regulatory and MLR review process. True, dynamic, personalized messaging requires that individualized content variants can be reviewed and approved at speed. Most pharma MLR workflows were not built for that. When every message variant must pass through the same review cycle as a static print piece, the system becomes a bottleneck to personalization, not an enabler of it. Solving the data infrastructure problem without also rethinking the content approval model will leave organizations stuck at Stage 3 regardless of how sophisticated their technology stack becomes.

It is also worth noting the sensitivity of patient and HCP data, HIPAA, and evolving consent frameworks, which means that personalization in this industry requires a level of governance discipline that other verticals do not face. That is not an excuse for slow progress, however. It’s a design requirement.

Progressing From Integration to Orchestration

Campaign execution is how most pharma commercial teams operate today. A plan is developed, assets are produced, channels are activated, and the cycle repeats. Orchestration is fundamentally different. It means that engagement is triggered by what the customer does, informed by what you know about them, and coordinated across channels in real time.

This is what the difference looks like in practice: instead of sending a brand email to all HCPs in a target segment on the first Tuesday of the month, an orchestrated program sends a specific message to a specific HCP because she just pulled a sample, her prescription volume suggests she is in a decision window, and the CRM shows her last rep visit was two weeks ago. The email is not campaign cadence. It is a response to a signal.

This is where next-best-action decisioning becomes relevant. Next-best-action uses unified customer data, business rules, and machine learning to determine what engagement should happen next for each individual customer. It replaces the static campaign calendar with a dynamic, customer-driven logic.

AI and advanced analytics play a big role here, but it has to start with integrated data. The organizations seeing the most value are not the ones that bought an AI platform. They are the ones that got their data in order first and then applied analytics to a clean, unified foundation. Technology doesn’t replace the data infrastructure, it amplifies it.

The stakes extend beyond commercial performance.

When orchestration works, and the right HCP receives the right information at the right moment in a patient’s treatment journey, it creates conditions for better clinical decisions.

The gap between a well-timed rep visit that reinforces a patient support resource and a fragmented engagement that leaves an HCP without the information they need is not just a marketing failure. It is a missed opportunity to improve patient outcomes. That connection does not get made enough in conversations about omnichannel maturity, but it is the most important reason to get this right.

A Practical Roadmap for Moving Forward

Given where most organizations are today, this can seem daunting. But it doesn’t need to be solved all at once. Progress is possible and valuable at every stage of the maturity curve. The key is being intentional about where you are starting and what you are building toward.

Assess honestly. Before investing in new technology or new channels, understand where your current capabilities actually sit. Map your data flows, identify where identity breaks down, and audit how well your stack integrates. The audit itself tends to surface the two or three integration problems worth solving first.

Prioritize high-impact integration use cases. Not all integration problems are equally valuable to solve. Start with the connections that will have the most direct impact on customer experience and commercial outcomes—in most cases, linking CRM, digital engagement, and field activity data.

Modernize the content approval model in parallel. Data integration without a corresponding investment in modular content and agile MLR reviews will quickly hit a ceiling. Organizations that want to execute true personalization need approval frameworks designed for content variants, not just campaigns.

Pilot orchestration in a focused area. Choose one brand or one customer segment and build an orchestrated engagement model within that scope. Prove the value, learn from what doesn’t work, and use the results to build the internal case for broader investment.

Iterate and scale. Omnichannel maturity is not a project with a completion date. It is a capability that improves with investment, measurement, and organizational learning. The goal is not a perfect system from day one. It is a system that gets better.

Looking Ahead: What the Next Wave Requires

HCPs and patients are developing higher expectations for relevant, coordinated engagement, shaped in large part by the experiences they have with leading consumer brands. Real-world data is becoming more accessible and more central to how commercial decisions are made. And AI is creating genuine new capabilities in personalization and decision-making for organizations that have the data infrastructure to use it.

The organizations that will lead the next wave of healthcare engagement are not necessarily the ones with the biggest budgets or the most channels.

They are the ones that have done the hard work of getting their data in order, building the capabilities to activate it, and aligning their teams, including medical affairs, IT, and regulatory, around a desire to better serve and better understand the customer.

The gap between organizations that have made those investments and those that have not will only widen as AI-driven capabilities become more central to commercial execution.

Omnichannel maturity is not primarily a marketing challenge. It is a data challenge that ends up manifesting itself in marketing outcomes, or a lack thereof. Part 2 of this series takes up that data challenge: what integration actually means, what fragmentation costs when it goes unsolved, and how to tell whether your organization is making progress.

Part 2, “The Data Behind the Omnichannel Promise: Why Integration Is the Linchpin” by Ashley Mahoney, examines the data integration challenge underneath omnichannel maturity and discusses what fragmentation actually costs and how to measure real progress.

https://deerfieldgroup.com/news/the-omnichannel-promise-pt2